Jose-Carlos (“JC”) is the Chief Science Officer of Danaher Corporation. In this role, JC is responsible for setting Danaher Science and Technology strategy and its implementation. This includes supporting existing and new M&A efforts, Venture Investments and other access channels to access external innovation. The Danaher CSO works with the Group executives, Company Presidents and their Chief Technical officers and R&D leaders to ensure the technical merit, scientific quality and optimized execution and balance between R&D for innovative and existing programs. To support these efforts, he leads the Danaher Venture group, the S&T Innovation group, the CXO team and the Danaher Scientific Advisory Board.
JC has diverse leadership experience across multiple biotech start-ups and pharmaceutical companies and deep expertise in translating new areas of science and technology into successful drug discovery and development programs and marketed drugs. Prior to Danaher, JC served as Global Head of Drug Discovery at AbbVie, Group SVP Biotherapeutics R&D at Pfizer, and SVP and CEDD Head of Immuno Inflammation at GlaxoSmithKline. JC was the founding CEO and President at Repertoire Immune Medicine where he built and led a team to decode the human immunome. Previously, he was President and CEO of Synlogic, where he led the company from early discovery to the clinical stage and to the public markets. In these global positions, he oversaw multiple drug discovery teams, resulting in five marketed drugs. He serves as director on the board of several biotechnology companies. He started his career as an academic researcher with faculty positions at the Basel Institute in Switzerland and Harvard Medical School in Boston.
